Hemidystonia:A Report of 22 Patients & a Review of the Literature
JNNP 48:650-657, Pettigrew,L.C.&Jankovic,J., 1985
The Regenerate Nervous System
Editorial, Lancet 1:1137-11381985., , 1985
Streptokinase & the Guillain-Barre Syndrome
Ann Int Med 103:302, Arrowsmith,J.B.,et al, 1985
Amytrophic Lateral Sclerosis:Part 2, Etiopathogenesis
Ann Neurol 18:419-431, Tandan,R.,et al, 1985
ALS & Pet Exposure
Neurol 35:717-720, Tarras,S.,et al, 1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985
Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Reappraisal of Temporary Levodopa Withdrawal ("Drug Holiday") in Parkinson's Disease
NEJM 313:724-728, Mayeux,R.,et al, 1985
"Drug Holiday"in the Treatment of Parkinson's Disease, A Brief Review
Arch Int Med 145:913-915, Friedman,J.H., 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Reversal of Sleep Disturbance in Parkinson's Disease by Antiparkinsonian Therapy:A Preliminary Study
Neurol 35:527-532, Askenasy,J.J.M.,et al, 1985
The Heterogeneity of Parkinson's Disease:Clinical & Prognostic Implications
Neurol 35:522-526, Zetusky,W.J.,et al, 1985
Association Between Essential Tremor & Parkinson's Disease
Ann Neurol 17:329-333, Gereghty,J.J.,et al, 1985
Low Cancer Rates Among Patients with Parkinson's Disease
Ann Neurol 17:505-509, Jansson,B.,et al, 1985
Radial Compression Neuropathy in Advanced Parkinson's Disease
Arch Neurol 42:695-696, Preston,D.N.,et al, 1985
Severe Compression Neuropathy Following Sudden Onset of Parkinsonian Immobility
Arch Neurol 42:720, Kurlan,R.,et al, 1985
Reversible Parkinsonism Related to Meperidine
NEJM 312:509, Lieberman,A.N.,et al, 1985
The Nucleus Basalis of Meynert in Neurological Disease:A Quantitative Morphological Study
Ann Neurol 17:163-170, Rogers,J.D.,et al, 1985
L-Dopa-Induced Respiratory Disturbance in Parkinson's Disease Suppressed by Tiapride
Neurol 35:235-237, DeKeyser,J.,et al, 1985
Acute Exacerbation of Parkinson's Disease with Sulindac
Ann Neurol 17:104-105, Sandyk,R.,et al, 1985
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
"Apraxia"of Eyelid Opening:An Involuntary Levator Inhibition
Neurol 35:423-427, Lepore,F.E.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Sharing of Antigenic Determinants Between the Nicotinic Ach Receptor & Proteins in Ecoli, Prot Vulgaris & Pneumoniae
NEJM 312:221-225, Stefansson,K.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Late-Onset Hallervorden-Spatz Disease Presenting as Familial Parkinsonism
Neurol 35:227-234, Jankovic,J.,et al, 1985
Prevalence of Parkinson's Disease in the Biracial Population of Copiah County, Mississippi
Neurol 35:841-845, Schoenberg,B.S.,et al, 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Olfactory Dysfunction in Alzheimer's Disease & Parkinson's Disease
Am J Psychiatry 142:781-782, Serby,M.,et al, 1985
Cyanide-Induced Parkinsonism:A Clinicopathologic Report
Neurol 35:921-925, Uitti,R.J.,et al, 1985
Octacosanol in Parkinsonism
Ann Neurol 16:723, Snider,S.R., 1984
Chediak-Higashi Syndrome
Arch Neurol 41:1001-1002, Pettit,R.E.,et al, 1984
Trigeminal Neuralgia:Current Concepts Regarding Etiology & Pathogenesis
Arch Neurol 41:1204-1207, Fromm,G.H.,et al, 1984
Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984
Parkinsonism & Basal Ganglia Infarcts
Neurol 34:1516-1518, Tolosa,E.S.,et al, 1984
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
How Common is Dementia In Parkinson's Disease
Lancet 2:1262-1265, Brown,R.G.,et al, 1984
Response Variations in the Treatment of Parkinson's Disease
Neurol 34:1507-1509, deJong,G.J.,et al, 1984
Epidemiology of Parkinsonism:Incidence, Classification, & Mortality
Ann Neurol 16:278-282, Rajput,A.H.,et al, 1984
Chronic Low-Dose Levodopa Therapy in Parkinson's Disease:An Argument for Delaying Levodopa Therapy
Neurol 34:991-996, Rajput,A.H.,et al, 1984
Peripheral Beta-Adrenergic Blockade Treatment of Parkinsonian Tremor
Ann Neurol 16:505-508, Foster,N.L.,et al, 1984
Sensory Symptoms in Parkinson's Disease
Neurol 34:957-959, Koller,W.C., 1984
Pathologic Laughing & Crying Treated with Levodopa
Arch Neurol 41:1095-1096, Udaka,F.,et al, 1984
Migraine Is A Food-Allergic Disease
Lancet 2:719-721, Monro,J.,et al, 1984
Migraine:A Cerebral Disorder
Lancet 2:86-89, Pearce,J.M.S., 1984
Guillaine-Barre Syndrome & Campylobacter Jejuni:A Serological Study
BMJ 288:1867-1870, Kaldor,J.,et al, 1984